🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is researching an experimental drug called garetosmab, referred ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2027-02-02
Trial ID
NCT07559513
Treatments Being Tested
The primary objective is to assess the safety and tolerability of REGN2477 ...
Status
Completed
Location
Multiple Locations
Start Date
2016-12-08
Trial ID
NCT02943239
This study is researching experimental drugs called trevogrumab and garetos...
Status
Active Not Recruiting
Location
Pinnacle Research Group
Start Date
2024-03-13
Trial ID
NCT06299098
This study is researching an experimental drug called garetosmab. The study...
Status
Active Not Recruiting
Location
University of California Los Angeles (UCLA) Medical Center
Start Date
2022-11-21
Trial ID
NCT05394116
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of REGN2477+...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02-19
Trial ID
NCT03710941
Treatments Being Tested
The objective of this Expanded Access Program (EAP) is to provide garetosma...
Status
Temporarily Not Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07301450
Treatments Being Tested
The primary objective of the study is to assess the safety and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2016-07
Trial ID
NCT02870400
The primary safety objective of the study is to assess the safety and toler...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-13
Trial ID
NCT04577820
Treatments Being Tested
This study is researching an experimental drug called garetosmab, referred ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-05-29
Trial ID
NCT06970405
Treatments Being Tested
This is a three period study design consisting of a 6-month, randomized, do...
Status
Completed
Location
Mayo Clinic
Start Date
2018-02-26
Trial ID
NCT03188666
Treatments Being Tested